2026. 9.1-9.3

上海新国际博览中心 N1-N4

距离展会

Sustainable textile coatings for medical applications

In recent years, Covestro has developed new polyurethane raw materials for state-of-the-art wound care under the trade name of Baymedix®. These include raw materials for wound dressings that assist in the healing process and also offer numerous design options. These raw materials are used, for example, in absorbent foams manufactured from Baymedix® FP, adhesives with skin contact made of Baymedix® A and films based on the waterborne products Baymedix® FD and CD.

A new focus of Covestro’s material developments are applications in medical textile coatings, for example in surgical clothing, mattress pads for hospitals, coatings for medical furniture and medical bandages. The company is presenting its raw materials for sustainable waterborne textile coatings that have good tactile properties and improved resistance to disinfectants at the Compamed trade show in Düsseldorf, Germany, from November 14 to 17. These materials are also suitable for latex-free elastic self-adhesive bandages and secondary fixing. 

Covestro is additionally showcasing material solutions with thermoplastic polyurethane films and the high-performance plastic polycarbonate (PC) that fulfill the demands of both medical technology manufacturers and patients.


About Covestro:
With 2015 sales of EUR 12.1 billion, Covestro is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction and the sports and leisure industries. Covestro, formerly Bayer MaterialScience, has 30 production sites around the globe and as of the end of 2015 employed approximately 15,800 people (full-time equivalents).

Find more information at www.covestro.com.
Follow us on Twitter: www.twitter.com/Coves

2026年上海医疗器械展|【专家共识】植入式脑机接口临床应用路径管理中国专家共识(2026版)

2026年上海医疗器械展关注到,植入式脑机接口(iBCI)技术通过直接采集皮层表面或皮层内/下神经信号并解码,驱动外部设备或进行神经刺激,最终实现运动、言语或感觉功能的重建。目前,国内iBCI临床试验加速发展,出现较多突破,但仍缺乏临床应用路径的规范化管理标准。

查看更多 »

2026年上海医疗器械展|手术机器人全国统一价格立项:血管介入机器人临床应用迎来关键制度拐点

2026年上海医疗器械展关注到,近日,国家医疗保障局正式发布《手术和治疗辅助操作类医疗服务价格项目立项指南(试行)》,明确提出将“手术机器人等辅助操作类医疗服务”纳入全国统一的医疗服务价格项目体系。这一文件的出台,标志着我国在手术机器人临床应用、医疗服务定价以及支付制度建设层面,迈出了具有里程碑意义的一步。

查看更多 »

2026年上海医疗器械设计与制造展|复旦大学“纤维芯片”刷屏!有望成脑机接口重要支撑

2026年上海医疗器械设计与制造展了解到,1月22日,据复旦大学官微,复旦大学纤维电子材料与器件研究院、高分子科学系、先进材料实验室、聚合物分子工程全国重点实验室彭慧胜、陈培宁团队突破传统芯片硅基研究范式,近日率先提出并制备“纤维芯片”,相关成果以《基于多层旋叠架构的纤维集成电路》为题于北京时间1月22日凌晨发表于国际期刊《自然》(Nature)。

查看更多 »

感谢您关注Medtec 国际医疗器械设计与制作技术展览会
预登记将于20264月开启
敬请期待